Gain insight and explore best practice recommendations for medication safety, with a special focus on high-risk processes which include GLP-1 receptor agonists, injectable therapies, and the informed consent process. Viewers will learn how to apply ISMP guidelines and mitigation strategies to reduce medication errors, improve patient outcomes, and strengthen safety culture in a variety of care settings. Real-world scenarios, reported errors, and practical tools will be shared to support safer prescribing, administration, and documentation practices.
Objectives:
• Evaluate high risk medication processes in a variety of healthcare settings.
• Apply evidence-based guidelines to enhance medication safety.
• Strengthen informed consent practices to support patient safety and risk management.
Broadcast date: January 20, 2026
Intended Audience(s): Risk Managers, Clinic Managers, Leadership
Download Slides
